BCI-215
BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.
Product Specifications
CAS Number
1245792-67-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
396.3
Molecular Formula
C22H22BrNO
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2147136-01 0.1 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details 
MBS2147136-02 0.2 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details MBS2147136-03 0.5 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details 
MBS2147136-04 1 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details MBS2147136-05 5 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details MBS2147136-06 5x 5 mL
APC-Linked Monoclonal Antibody to Cluster Of Differentiation (CD163)
Ask
View Details